Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional
This Brief defines competitive intelligence (CI) as a tool for making investment decisions within the pharmaceutical industry. It provides an overview of processes that the regulatory affairs professional must take into account when evaluating data impacting product-based risk evaluations. These ap...
Sparad:
| Huvudupphovsman: | |
|---|---|
| Institutionell upphovsman: | |
| Materialtyp: | Elektronisk E-bok |
| Språk: | English |
| Publicerad: |
New York, NY :
Springer New York : Imprint: Springer,
2012.
|
| Upplaga: | 1st ed. 2012. |
| Serie: | SpringerBriefs in Pharmaceutical Science & Drug Development,
|
| Ämnen: | |
| Länkar: | https://doi.org/10.1007/978-1-4614-3682-9 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|